投稿信息
投稿信息
审稿周期
投稿命中率
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
2.8 %
年文章数
642
NCBI查询
期刊简介
稿件收录要求
稿件收录要求
Journal of Cardiovascular Pharmacology and Therapeutics is a peer-reviewed journal that publishes original basic human studies, original animal studies, and original bench research with potential clinical application to cardiovascular pharmacology and therapeutics. The focus of the experimental studies is translational research. The journal also publishes review articles on basic research, clinical research, editorials, commentaries, points of view, and controversies. Selected journal supplements will also be published. Future focus will include cardioprotective therapies, stem cell therapy, regenerative cardiology, therapies for preventive cardiology (risk factor management), and antiarrhythmic therapies. Selected journal supplements will also be published.
Every informative issue of Journal of Cardiovascular Pharmacology and Therapeutics (JCPT) offers cardiologists, clinical pharmacologists and researchers involved in disease relevant clinical and experimental investigations of newer cardiovascular drugs and other therapeutic options. Four times a year, JCPT examines and analyzes arenas such as:
- Agents that Reduce Myocardial Infarct Size
- Agents that Reduce Myocardial Remodeling
- Angiotensin Converting Enzyme Inhibitors
- Antihypertensive Therapy
- Arrhythmias
- Atrial Fibrillation
- Beta-Blocker Therapies
- Cardioembolic Stroke
- Cardiomyopathy
- Cardioprotective Agents
- Cardiopulmonary Resuscitation
- Cardiovascular Combination Therapies
- Chronic Angina
- Chronic Cardiac Ischemia
- Congestive Heart Failure
- Coronary Artery Disease
- Coronary Revascularization
- Heparin Therapies
- Hypertension
- Hypotension
- Implantable Devices
- Ischemic Heart Disease
- Myocardial Infarction
- Percutaneous Coronary Interventions
- Peripheral Arterial Disease
- Preconditioning/Postconditioning
- Regenerative Cardiology
- Stem Cell Therapy
